Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic partnership with BlueWhale Bio, a commercial-stage company dedicated to transforming immune cell therapy manufacturing and addressing th…
Viatris Inc. a global healthcare company, announced it has acquired Aculys Pharma, Inc., a clinical stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions. Viatris received rights to develop and commercialize pitolisant and Spydia®, two assets in the Central Nervou…
Pfizer Inc. and Metsera, Inc. announced the companies have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases. The acquisition brings deep expertise and a portfoli…
Roche announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and strengthen Hong Kong's role as a leading hub for life sciences and medical technology in the Asia Pacific region. As part of this announcement, Roche will strengthen its pre…
ADC Therapeutics a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), announced that it has entered into securities purchase agreements for the sale of its equity securities to certain institutional investors in a $60.0 million private investment in public equity ("PIPE") fina…
Chance Pharmaceuticals, a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, announced that it has reached an exclusive commercialization agreement with Huadong Medicine (Hangzhou) Co., Ltd., a wholly owned subsidiary of Huadong Medicine Co., Ltd., to com…
Novo Nordisk announced that it has entered into a definitive agreement to acquire Akero Therapeutics, Inc. (Akero), a publicly held clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need. Akero’s fibroblast growth factor 21 (FGF21) analo…
PureHealth Holding PJSC, the largest healthcare group in the Middle East, announced the successful completion of the acquisition of its 60% stake in Hellenic Healthcare Group (HHG), Greece and Cyprus's leading private healthcare provider, for a total consideration of EUR 800 million. The transaction implies a 100% equ…
Zimmer Biomet Holdings, Inc., a global medical technology leader, announced it has completed the acquisition of Monogram Technologies Inc. ("Monogram"), an AI-driven, next-generation orthopedic robotics company. Monogram's surgeon-guided semi- and fully autonomous robotic technologies are expected to add new and diff…
Saya Biologics (Saya Bio), a Mexican biopharmaceutical company committed to expanding patient access to innovative, high-quality, and affordable biological treatments, and Maxigen Biotech Inc., an international company specializing in the development and manufacture of hyaluronic acid-based therapeutic solutions, ann…
Page 29 of 40